Abstract

The most progress has been made on SARS-CoV E, highlighting specific structural requirements for its functions in the CoV life cycle as well as mechanisms behind its pathogenesis. Data shows that E is involved in critical aspects of the viral life cycle and that CoVs lacking E make promising vaccine candidates. The high mortality rate of certain CoVs, along with their ease of transmission, underpins the need for more research into CoV molecular biology which can aid in the production of effective anti-coronaviral agents for both human CoVs and enzootic CoVs.

Keywords

BiologyEnzooticCoronavirusViral pathogenesisViral life cycleMiddle East respiratory syndrome coronavirusVirologyMiddle East respiratory syndromeViral envelopeComputational biologyCoronavirus disease 2019 (COVID-19)VirusViral replicationDiseaseInfectious disease (medical specialty)Medicine

MeSH Terms

AnimalsCoronavirusCoronavirus InfectionsHumansSevere acute respiratory syndrome-related coronavirusSevere Acute Respiratory SyndromeViral Envelope ProteinsZoonoses

Affiliated Institutions

Related Publications

2019 NOVEL CORONAVIRUS.

In December 2019, the outbreak of a new disease began in Wuhan, Hubei Province, China. The causative agent of the new disease outbreak was identified as 2019 novel Coronavirus 2...

2019 PubMed 19 citations

Publication Info

Year
2019
Type
review
Volume
16
Issue
1
Pages
69-69
Citations
2144
Access
Closed

Social Impact

Social media, news, blog, policy document mentions

Citation Metrics

2144
OpenAlex
77
Influential

Cite This

Dewald Schoeman, Burtram C. Fielding (2019). Coronavirus envelope protein: current knowledge. Virology Journal , 16 (1) , 69-69. https://doi.org/10.1186/s12985-019-1182-0

Identifiers

DOI
10.1186/s12985-019-1182-0
PMID
31133031
PMCID
PMC6537279

Data Quality

Data completeness: 86%